{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T11:40:50Z","timestamp":1774784450292,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":5754,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1046\/j.1523-1747.2000.00867.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T05:52:35Z","timestamp":1047448355000},"page":"514-519","source":"Crossref","is-referenced-by-count":44,"title":["p53-Dependent Apoptosis in Melanoma Cells After Treatment with Camptothecin 1"],"prefix":"10.1016","volume":"114","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/mutage\/13.3.257","article-title":"Distribution of camptothecin-induced break points in Chinese hamster cells treated in late S and G2 phases of the cell cycle","volume":"13","author":"Bassi","year":"1998","journal-title":"Mutagenesis"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0015","first-page":"1941","article-title":"Apoptosis-related factors p53, Bcl-2, and Bax in neuroendocrine lung tumors","volume":"149","author":"Brambilla","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0020","first-page":"423","article-title":"Cell migration and actin organization in cultured human primary, recurrent cutaneous and metastatic melanoma","volume":"139","author":"Byers","year":"1991","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0025","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archderm.1993.01680270077009","article-title":"p53 protein expression in nevi and melanomas","volume":"129","author":"Cristofolini","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0030","first-page":"1217","article-title":"The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2","volume":"11","author":"Eliopoulos","year":"1995","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0035","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/blood.V89.8.2986","article-title":"Expression and regulation of bcl-2, bcl-xl, and bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia","volume":"89","author":"Findley","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0040","first-page":"2973","article-title":"Multidrug resistance related genes and p53 expression in human non small cell lung cancer","volume":"18","author":"Galimberti","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0959-437X(95)90058-6","article-title":"Biochemical properties and biological effects of p53","volume":"5","author":"Haffner","year":"1995","journal-title":"Curr Opin Genet Dev"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1097-0215(19960729)67:3<313::AID-IJC1>3.0.CO;2-U","article-title":"Overexpression and mutations of p53 in metastatic melanomas","volume":"67","author":"Hartmann","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nm0298-232","article-title":"bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice","volume":"4","author":"Jansen","year":"1998","journal-title":"Nature Med"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s002800050690","article-title":"Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells","volume":"40","author":"Jones","year":"1997","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0065","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0925-5710(98)00038-3","article-title":"Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy","volume":"68","author":"Kamesaki","year":"1998","journal-title":"Int J Hematol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0070","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF01209030","article-title":"MDR1 expression correlated with mutant expression in colorectal cancer metastases","volume":"122","author":"de Kant","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0075","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.4049\/jimmunol.160.12.5735","article-title":"The trophic action of IL-7 on pro-T cells: inhibition of apoptosis of pro-T1-T2, and -T3 cells correlates with Bcl-2 and Bax levels and is independent of Fas and p53 pathways","volume":"160","author":"Kim","year":"1998","journal-title":"J Immunol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0080","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1038\/sj.onc.1201681","article-title":"Overexpression of bax gene sensitizes K562 erythroleukemia cells to apoptosis induced by selective chemotherapeutic agents","volume":"16","author":"Kobayashi","year":"1998","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1056\/NEJM199107183250306","article-title":"Cutaneous melanoma","volume":"325","author":"Koh","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0090","first-page":"885","article-title":"Significance of P-53 antigen in malignant melanomas and naevi of the head and neck area","volume":"15","author":"Korabiowska","year":"1995","journal-title":"Anticancer Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0095","first-page":"2235","article-title":"Overexpression of p53 is a late event in the development of malignant melanoma","volume":"53","author":"Lassam","year":"1993","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0926-9959(94)00071-7","article-title":"p53 mutation in metastatic melanomas and primary melanomas from sun-exposed and sun-protected sites","volume":"4","author":"Li","year":"1995","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0105","first-page":"1113","article-title":"Decreased DNA repair but normal apoptosis in UV-exposed keratinocytes of p53 transgenic mice","volume":"148","author":"Li","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00008390-199802000-00004","article-title":"Chemotherapy-induced apoptosis in melanoma cells is p53 dependent","volume":"8","author":"Li","year":"1998","journal-title":"Melanoma Res"},{"issue":"Suppl.","key":"10.1046\/j.1523-1747.2000.00867.x_bb0115","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s002800051053","article-title":"Multidrug resistance: molecular mechanisms and clinical relevance","volume":"40","author":"Ling","year":"1997","journal-title":"Cancer Chemotherapy Pharmacol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/bjc.1996.316","article-title":"p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer","volume":"74","author":"Linn","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0125","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/362847a0","article-title":"p53 is required for radiation-induced apoptosis in mouse thymocytes","volume":"362","author":"Lowe","year":"1993","journal-title":"Nature"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0130","first-page":"3087","article-title":"Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer","volume":"18","author":"Miyake","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0135","first-page":"1799","article-title":"Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo","volume":"9","author":"Miyashita","year":"1994","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1749-6632.1996.tb26391.x","article-title":"Camptothecin and its analogs. An overview of their potential in cancer therapeutics","volume":"803","author":"Muggia","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0145","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0145-2126(95)00048-8","article-title":"The water-insoluble camptothecin analogues: promising drugs for the effective treatment of haematological malignancies","volume":"19","author":"Pantazis","year":"1995","journal-title":"Leukemia Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3109\/10428199809092690","article-title":"Elevated Bcl-2\/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance","volume":"28","author":"Pepper","year":"1998","journal-title":"Leukemia Lymphoma"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF02904701","article-title":"Drug resistance in ovarian cancer\u2013-the role of p53","volume":"4","author":"Petty","year":"1998","journal-title":"Pathol Oncol Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0165","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb00067.x","article-title":"Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin\u2019s lymphoma","volume":"22","author":"Pezzella","year":"1993","journal-title":"Histopathology"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0170","first-page":"262","article-title":"Survival with regional and distant metastases from cutaneous malignant melanoma","volume":"172","author":"Roses","year":"1991","journal-title":"Surg Gynecol Obstet"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008270717294","article-title":"inhibitors review and update","volume":"8","author":"Rothenberg","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0180","first-page":"1077","article-title":"Apoptosis as a criterion for sensitivity of uterine cervical adenocarcinoma to cisplatin","volume":"5","author":"Sekiguchi","year":"1998","journal-title":"Oncol Rep"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0190","first-page":"4164","article-title":"Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage","volume":"53","author":"Slichenmyer","year":"1993","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0195","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/00008390-199504000-00004","article-title":"p53 gene mutation and expression in naevi and melanomas","volume":"5","author":"Sparrow","year":"1995","journal-title":"Melanoma Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00173681","article-title":"Topoisomerase I interactive drugs in children with cancer","volume":"14","author":"Stewart","year":"1996","journal-title":"Invest New Drugs"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0205","doi-asserted-by":"crossref","first-page":"11037","DOI":"10.1073\/pnas.94.20.11037","article-title":"p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents","volume":"94","author":"Thottassery","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0210","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0002-9440(10)65600-3","article-title":"p53-regulated apoptosis is differentiation-dependent in UVB irradiated mouse keratinocytes","volume":"153","author":"Tron","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0215","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1995.tb02487.x","article-title":"Expression of the p53 protein in malignant melanoma: clinicopathological and prognostic implications","volume":"133","author":"Weiss","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF01262323","article-title":"Expression of the p53 protein in malignant melanoma as a prognostic indicator","volume":"287","author":"Yamamoto","year":"1995","journal-title":"Arch Dermatol Res"},{"key":"10.1046\/j.1523-1747.2000.00867.x_bb0225","doi-asserted-by":"crossref","first-page":"15387","DOI":"10.1074\/jbc.273.25.15387","article-title":"Wild-type p53-mediated induction of rat mdr1b expression by the anticancer drug daunorubicin","volume":"173","author":"Zhou","year":"1998","journal-title":"J Biol Chem"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15408036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15408036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T17:20:30Z","timestamp":1682097630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15408036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S0022202X15408036"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00867.x","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}